Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have been diagnosed with cancer at stage I, II, or III
- People who have mild nerve damage (grade 1) related to chemotherapy, sometimes called CIPN
- People who are currently receiving chemotherapy for cancer, or who have already received it
- People who can speak, read, and understand English
Who may not be able to join:
- People who have medical conditions that can also cause nerve damage symptoms, such as diabetes
- People who have any medical conditions that are not currently well managed or controlled
- People who are planning to have surgery or radiation therapy at any point during the study period
- People who are already taking part in a structured aerobic exercise training program
- People who are already participating in another research study that involves exercise
- People who are unable to sign a consent form agreeing to take part in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Margaret L McNeely, PhD, University of Alberta
Phone: 1-780-492-6007
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Recruitment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.